About this trial
The purpose of this study is to evaluate the predictive value of CPR discordance at 16-20 weeks in MCDA twin pregnancies in predicting monochorionic-specific complications such as TTTS, TAPS, sFGR and IUFD of one or both fetuses
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Aged 18 years or more and able to consent.
Monochorionic Diamniotic twin pregnancy.
Discordant inter-twin cerebroplacental ratio at 16-20 weeks of gestation.
Disqualifiers
Fetal structural malformations or chromosomal abnormalities in any of the twins as detected by anomaly scan antenatally or neonatal examination postnatally (chromosomal abnormalities and some congenital malformations can interfere with normal fetal growth).
Identified infectious etiologies detected during immediate postnatal examination or during pregnancy (fetal infections can cause FGR ,usually symmetric type particularly if they occur in early gestation).
Referral after development of Twin to twin transfusion syndrome, twin anemia polycythemia sequence or selective fetal growth restriction.
Single fetal demise at the time enrollment in the study.
Trial population
Monochorionic diamniotic twin pregnancies with discordant cerebroplacental ratio at 16-20 weeks of gestation presenting to Ain Shams University Maternity Hospital for antenatal care.
Trial design
Cohort
Prospective
Treatments tested in this trial
Ultrasound
DeviceMeasuring cerebroplacental ratio discordance in monochorionic twins at 16-20 Weeks of gestation
Treatment groups
Trial outcomes
Primary outcomes
Development of monochorionic specific complications
Monochorionic specific complications include twin to twin transfusion syndrome, twin anemia polycythemia sequence and selective fetal growth restriction
Secondary outcomes
Occurrence of intrauterine fetal death or perinatal mortality of one or both fetuses
Gestational age upon occurrence of IUFD with clarifying if complications occur in the surviving twin in case of single fetal demise. Time and reason of perinatal mortality for any of the fetuses Wil be recorded.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.